Outlook 2025: Key Trends & Insights

As 2025 approaches, the pharmaceutical industry stands at a pivotal moment of transformation. Artificial intelligence (AI) is rapidly reshaping drug discovery, development, and commercialization, offering unprecedented efficiencies and innovations. To fully capitalize on AI’s potential, pharma companies must adopt strategic, industry-wide implementations that go beyond isolated applications. However, this era of advancement is tempered by significant geopolitical risks. Regional instability and evolving regulatory frameworks threaten global supply chains, requiring robust risk management strategies to ensure operational resilience.

This eBook is part of In Vivo’s comprehensive Outlook 2025 report and explores the trends shaping pharma’s future, from geopolitical pressures to cutting-edge innovations in AI, oncology, and weight-loss treatments. It provides essential insights into the forces that will define the evolving landscape of pharmaceuticals and medtech in the year ahead.